Trials / Unknown
UnknownNCT03108391
A Comparison of the Ambu®AuraGain™ and the Laryngeal Mask Airway Supreme™ in Normal Airway Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Chinese Academy of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed to compare the performance of the Ambu AuraGain Laryngeal Mask Airway and LMA Supreme in normal airway patients.
Detailed description
Ambu AuraGain Laryngeal Mask Airway is a newly designed supraglottic device. We design this study to test its clinical performance in normal airway patients, in comparison with LMA Supreme.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ambu AuraGain | |
| DEVICE | LMA Supreme |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2017-10-31
- Completion
- 2017-10-31
- First posted
- 2017-04-11
- Last updated
- 2017-04-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03108391. Inclusion in this directory is not an endorsement.